ticagrelor has been researched along with Vomiting* in 2 studies
2 other study(ies) available for ticagrelor and Vomiting
| Article | Year |
|---|---|
Impact of vomiting on P2Y12 platelet inhibition in patients with ST-elevation myocardial infarction: A prespecified subanalysis of the ON-TIME 3 trial.
Vomiting is associated with lower levels of ticagrelor concentration and higher platelet reactivity in the early hours of ST-elevation myocardial infarction. These results support reloading with a ticagrelor loading dose and/or treatment with intravenous platelet inhibitors when patients vomit. Topics: Blood Platelets; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; ST Elevation Myocardial Infarction; Ticagrelor; Treatment Outcome; Vomiting | 2022 |
Ticagrelor-induced acute kidney injury can increase serum concentration of statin and lead to concurrence of rhabdomyolysis.
Topics: Acute Kidney Injury; Administration, Oral; Aged, 80 and over; Coronary Artery Disease; Diagnosis, Differential; Female; Humans; Nausea; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Rhabdomyolysis; Ticagrelor; Vomiting | 2018 |